Ongoing multi-state measles transmission, fueled by low vaccination coverage in certain communities and repeated importations via international travel, continues to drive rapid case growth and trader expectations for exceeding 1,900 confirmed U.S. cases by May 31. As of May 7, the CDC reported 1,842 cases in 2026, with 93 percent outbreak-associated across 25 new clusters and 36 states; roughly 92 percent of patients were unvaccinated or had unknown status. Weekly increments have slowed modestly from earlier peaks yet remain in the dozens, reflecting persistent community spread ahead of peak summer travel. Upcoming CDC weekly updates through late May, combined with any new laboratory confirmations, will directly influence final counts against historical baselines of 285 cases in 2024 and 2,288 for all of 2025.
สรุปจาก AI ทดลองที่อ้างอิงข้อมูลจาก Polymarket ไม่ใช่คำแนะนำในการเทรดและไม่มีผลต่อการตัดสินตลาดนี้ · อัปเดตแล้วMeasles cases in U.S. by May 31?
Measles cases in U.S. by May 31?
$69,809 ปริมาณ
May 31, 2026
1900
99%
1925
96%
1950
69%
2000
14%
2200
2%
2400
1%
$69,809 ปริมาณ
1900
$29,849 ปริมาณ
99%
1925
$5,462 ปริมาณ
96%
1950
$11,844 ปริมาณ
69%
2000
$14,274 ปริมาณ
14%
2200
$2,644 ปริมาณ
2%
2400
$955 ปริมาณ
1%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by May 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Ongoing multi-state measles transmission, fueled by low vaccination coverage in certain communities and repeated importations via international travel, continues to drive rapid case growth and trader expectations for exceeding 1,900 confirmed U.S. cases by May 31. As of May 7, the CDC reported 1,842 cases in 2026, with 93 percent outbreak-associated across 25 new clusters and 36 states; roughly 92 percent of patients were unvaccinated or had unknown status. Weekly increments have slowed modestly from earlier peaks yet remain in the dozens, reflecting persistent community spread ahead of peak summer travel. Upcoming CDC weekly updates through late May, combined with any new laboratory confirmations, will directly influence final counts against historical baselines of 285 cases in 2024 and 2,288 for all of 2025.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by May 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
ตลาดเปิดเมื่อ: Apr 29, 2026, 11:18 AM ET
ปริมาณการซื้อขาย
$69,809วันสิ้นสุด
May 31, 2026ตลาดเปิดเมื่อ
Apr 29, 2026, 11:18 AM ETResolver
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by May 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Ongoing multi-state measles transmission, fueled by low vaccination coverage in certain communities and repeated importations via international travel, continues to drive rapid case growth and trader expectations for exceeding 1,900 confirmed U.S. cases by May 31. As of May 7, the CDC reported 1,842 cases in 2026, with 93 percent outbreak-associated across 25 new clusters and 36 states; roughly 92 percent of patients were unvaccinated or had unknown status. Weekly increments have slowed modestly from earlier peaks yet remain in the dozens, reflecting persistent community spread ahead of peak summer travel. Upcoming CDC weekly updates through late May, combined with any new laboratory confirmations, will directly influence final counts against historical baselines of 285 cases in 2024 and 2,288 for all of 2025.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by May 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
ปริมาณการซื้อขาย
$69,809วันสิ้นสุด
May 31, 2026ตลาดเปิดเมื่อ
Apr 29, 2026, 11:18 AM ETResolver
0x65070BE91...Ongoing multi-state measles transmission, fueled by low vaccination coverage in certain communities and repeated importations via international travel, continues to drive rapid case growth and trader expectations for exceeding 1,900 confirmed U.S. cases by May 31. As of May 7, the CDC reported 1,842 cases in 2026, with 93 percent outbreak-associated across 25 new clusters and 36 states; roughly 92 percent of patients were unvaccinated or had unknown status. Weekly increments have slowed modestly from earlier peaks yet remain in the dozens, reflecting persistent community spread ahead of peak summer travel. Upcoming CDC weekly updates through late May, combined with any new laboratory confirmations, will directly influence final counts against historical baselines of 285 cases in 2024 and 2,288 for all of 2025.
สรุปจาก AI ทดลองที่อ้างอิงข้อมูลจาก Polymarket ไม่ใช่คำแนะนำในการเทรดและไม่มีผลต่อการตัดสินตลาดนี้ · อัปเดตแล้ว
ระวังลิงก์ภายนอก
ระวังลิงก์ภายนอก
คำถามที่พบบ่อย